Elongation factor like GTPase 1 pseudogene 1 (EFL1P1)

Elongation factor like GTPase 1 pseudogene 1 (EFL1P1) is classified as a **pseudogene** in the human genome[1][3]. While its sequence resembles those of functional elongation factors, it does not code for a protein and has no known functional product or role in protein translation. The designation "pseudogene" means it is considered a genetic relic from evolutionary duplication or retrotransposition events and is not involved in therapeutic mechanisms or biological pathways. Unlike the authentic elongation factor proteins (e.g., EFL1, EEF1A1), which participate in ribosome-mediated protein synthesis and are sometimes investigated in cancer and other diseases[5][3], EFL1P1 lacks any direct biological, mechanistic, or disease-related activity. There is no record of drugs, biomarkers, or safety signals associated with its locus. The similarity in aliases (such as "similar to hypothetical protein FLJ13119") reflects sequence similarity, not function[1]. As such, EFL1P1 should not be included as a therapeutic target or considered further for drug development or biomarker discovery.

Other names

HsT19321similar to hypothetical protein FLJ13119